Cross Site Scripting Vulnerability in erjinzhi 10OA by Unknown Vendor
CVE-2025-10274

5.3MEDIUM

Key Information:

Vendor

Erjinzhi

Status
10oa
Vendor
CVE Published:
12 September 2025

Badges

👾 Exploit Exists🟡 Public PoC

What is CVE-2025-10274?

A security flaw has been identified in the 'erjinzhi 10OA' version 1.0, allowing for a cross site scripting (XSS) vulnerability. This issue arises from the manipulation of the 'Name' argument within the '/trial/mvc/item' file, potentially enabling attackers to execute harmful scripts on unsuspecting users. The vulnerability can be exploited remotely, and an exploit has been made publicly available. Despite early notification attempts to the vendor regarding this vulnerability, there has been no response to address the issue.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

10OA 1.0

Exploit Proof of Concept (PoC)

PoC code is written by security researchers to demonstrate the vulnerability can be exploited. PoC code is also a key component for weaponization which could lead to ransomware.

CVE-2025-10274 - Proof of Concept

References

https://vuldb.com/?id.323644
vdb-entrytechnical-description
https://vuldb.com/?ctiid.323644
signaturepermissions-required
https://vuldb.com/?submit.643050
third-party-advisory

CVSS V4

Score:
5.3
Severity:
MEDIUM
Confidentiality:
None
Integrity:
Low
Availability:
None
Attack Vector:
Network
Attack Complexity:
Low
Attack Required:
None
Privileges Required:
Undefined
User Interaction:
Unknown

Timeline

  • 🟡

    Public PoC available

  • 👾

    Exploit known to exist

  • Vulnerability published

  • Vulnerability Reserved

Credit

Zre0x1c (VulDB User)
JSON
.